EUR 4.6
(-3.97%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 3.68 Million EUR | -17.33% |
2022 | 4.45 Million EUR | 374.61% |
2021 | 938.01 Thousand EUR | 155.67% |
2020 | 366.88 Thousand EUR | 0.0% |
2019 | - EUR | 0.0% |
2018 | - EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 FY | 3.68 Million EUR | -17.33% |
2023 Q2 | - EUR | -100.0% |
2022 Q4 | 4.45 Million EUR | 0.0% |
2022 Q2 | - EUR | -100.0% |
2022 FY | 4.45 Million EUR | 374.61% |
2021 Q4 | 938.01 Thousand EUR | 0.0% |
2021 FY | 938.01 Thousand EUR | 155.67% |
2021 Q2 | - EUR | -100.0% |
2020 Q2 | - EUR | 0.0% |
2020 Q4 | 366.88 Thousand EUR | 0.0% |
2020 FY | 366.88 Thousand EUR | 0.0% |
2019 FY | - EUR | 0.0% |
2018 FY | - EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
MPH Health Care AG | 13.05 Million EUR | 71.808% |
Apontis Pharma AG | 6 Million EUR | 38.662% |
Dermapharm Holding SE | 1.08 Billion EUR | 99.659% |
Evotec SE | 626.19 Million EUR | 99.412% |
MERCK Kommanditgesellschaft auf Aktien | 9.94 Billion EUR | 99.963% |
PharmaSGP Holding SE | 73.97 Million EUR | 95.025% |